Compare AU

Compare DRUG vs. BBUS

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the BetaShares Us Eqy Strong Bear - Ch (Hedge Fund) (BBUS). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

BBUS

Popularity

Low

Low

Pearlers invested

64

11

Median incremental investment

$943.50

$4,993.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,978.96

$2,069.44

Average age group

26 - 35

> 35


Key Summary

DRUG

BBUS

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

BBUS.AX was created on 2015-08-24 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to help investors profit from, or protect against, a declining U.S. share market. It seeks to generate magnified returns that are negatively correlated to the returns of the U.S. share market (as measured by the S&P 500 index), hedged to Australian dollars.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

S&P500 EMINI FUT SEP24 (0 %)

AUD - AUSTRALIA DOLLAR (98.14 %)

USD - UNITED STATES DOLLAR (1.86 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Other (73.66 %)

Communication Services (26.34 %)

Top 3 countries

United States (23.96 %)

Ireland (0.52 %)

France (0.00 %)

Management fee

0.57 %

1.38 %


Key Summary

DRUG

BBUS

Issuer

BetaShares

BetaShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

1.38 %

Price

$8.53

$4.64

Size

$197.947 million

$155.723 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

1.89 %

Market

ASX

ASX

First listed date

08/08/2016

26/08/2015

Purchase fee

$6.50

$6.50


Community Stats

DRUG

BBUS

Popularity

Low

Low

Pearlers invested

64

11

Median incremental investment

$943.50

$4,993.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,978.96

$2,069.44

Average age group

26 - 35

> 35


Pros and Cons

DRUG

BBUS

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

BBUS

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home